Clincosm LogoSign in Get a demo

Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients

Sponsor
Kanuni Sultan Suleyman Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01982526
Collaborator
(none)
30
Enrollment
1
Location
48
Duration (Months)
0.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Ovarian reserve influenced by many factor but especially cysts like endometrioma. Anti mullerian hormone is recent marker for ovarian reserve. The investigators are searching ovarian reserve pre and post operatively by using antimullerian hormone of endometrioma patient who are operated for their cysts.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    long term results of the postoperative follow up for the endometrioma patients

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    30 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients
    Study Start Date :
    May 1, 2012
    Actual Primary Completion Date :
    May 1, 2013
    Actual Study Completion Date :
    May 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Endmetrioma surgery

    Outcome Measures

    Primary Outcome Measures

    1. Long term postoperative ovarian reserve outcomes of endometrioma patients by examining antimullerian hormone. [2 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    17 Years to 42 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Ultrasonographical symptomatic and benign cysts which has surgery indication.
    Exclusion Criteria:
    • Over 42 years old, systemic endocrine disorder, history of ovarian surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kanuni Sultan Suleyman Education and Research Hospital Istanbul Turkey 34303

    Sponsors and Collaborators

    • Kanuni Sultan Suleyman Training and Research Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ergul Demircivi Bor, Medical Doctor, Kanuni Sultan Suleyman Training and Research Hospital
    ClinicalTrials.gov Identifier:
    NCT01982526
    Other Study ID Numbers:
    • 2011-84
    First Posted:
    Nov 13, 2013
    Last Update Posted:
    Aug 10, 2018
    Last Verified:
    Aug 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Ergul Demircivi Bor, Medical Doctor, Kanuni Sultan Suleyman Training and Research Hospital
    Ovarian reserve
    Antimullerian hormone
    Additional relevant MeSH terms:
    Endometriosis

    Study Results

    No Results Posted as of Aug 10, 2018